ANTIGEN PRESENTATION BY CLASS IB MOLECULES
IB 类分子的抗原呈递
基本信息
- 批准号:6235307
- 负责人:
- 金额:$ 13.71万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1997
- 资助国家:美国
- 起止时间:1997-09-01 至 1998-08-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Recent advances revealed that classical class I MHC molecules (class Ia),
crucial for cell-mediated immunity against pathogens, represent only a
small subset of the family of related proteins displaying potential for
antigen presentation. The candidate genes for nonclassical class I MHC
molecules (class Ib) were identified in all vertebrates including rodents
and man. In a few cases class Ib-binding peptides were characterized and
their structural features were used to deduce the physiological roles of
the presenting molecules. Thanks to this approach, it is now known that
murine H-2M3 class Ib molecules participate in the immune response against
intracellular pathogen, Listeria monocytogenes. The antigen presentation
functions of other class Ib proteins have not been yet defined. We propose
to examine the structural properties of self-peptides associated with five
different murine class Ib molecules. The specific aims are:
1) to perform a systematic analysis of anchor residues required for
binding to Q7 antigen, identify proteins that carry the Q7 binding motif,
synthesize the candidate peptide epitopes from known pathogens and test
for binding to Q7
2) to overexpress Q6, Q1O, Qa-1 and H-2M3 class Ib complexes in tissue
cultured cells and characterize peptides associated with these molecules,
using the strategies employed previously by us and our collaborators to
define SQ7-bound self-peptides.
The results of these studies will provide insights into the biological
significance of antigen presentation by class Ib molecules and will
generate information relevant to the understand in of their roles in
immune response against pathogens and tumors as well as their
participation in transplant rejection and in autoimmune reactions.
最近的进展表明,经典的I类MHC分子(Ia类),
对细胞介导的抗病原体免疫至关重要,仅代表
相关蛋白质家族的一个小子集显示出潜在的
抗原呈递非经典I类MHC的候选基因
在包括啮齿动物在内的所有脊椎动物中鉴定出分子(Ib类
在少数情况下,Ib类结合肽被表征,
它们的结构特征被用来推断生理作用,
呈现分子。由于这种方法,现在已知,
鼠H-2 M3 Ib类分子参与抗
胞内病原体单核细胞增生李斯特菌。抗原呈递
其它Ib类蛋白的功能尚未确定。我们提出
研究与五种蛋白质相关的自身肽的结构特性,
不同的鼠Ib类分子。具体目标是:
1)对所需的锚残基进行系统分析,
与Q7抗原结合,鉴定携带Q7结合基序的蛋白质,
合成来自已知病原体的候选肽表位,
用于结合Q7
2)在组织中过表达Q6、Q1 O、Qa-1和H-2 M3 Ib类复合物
培养细胞并表征与这些分子相关的肽,
使用我们和我们的合作者以前采用的策略,
定义SQ 7结合的自身肽。
这些研究的结果将提供对生物学的见解
Ib类分子抗原提呈意义及意愿
生成与了解其在以下方面的作用相关的信息:
针对病原体和肿瘤的免疫应答及其
参与移植排斥和自身免疫反应。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
IWONA T STROYNOWSKI其他文献
IWONA T STROYNOWSKI的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('IWONA T STROYNOWSKI', 18)}}的其他基金
CORE--TISSUE CULTURE AND MONOCLONAL ANTIBODY FACILITY
核心——组织培养和单克隆抗体设施
- 批准号:
6340683 - 财政年份:2000
- 资助金额:
$ 13.71万 - 项目类别:
CORE--TISSUE CULTURE AND MONOCLONAL ANTIBODY FACILITY
核心——组织培养和单克隆抗体设施
- 批准号:
6229706 - 财政年份:1995
- 资助金额:
$ 13.71万 - 项目类别:
TRANSPLANTATION ANTIGENS--EXPRESSION AND FUNCTION
移植抗原——表达和功能
- 批准号:
2060972 - 财政年份:1992
- 资助金额:
$ 13.71万 - 项目类别:
TRANSPLANTATION ANTIGENS--EXPRESSION AND FUNCTION
移植抗原——表达和功能
- 批准号:
2060970 - 财政年份:1992
- 资助金额:
$ 13.71万 - 项目类别:
相似海外基金
Defining MHC class I restricted antigen presentation to CD8 T cells in experimental AD and Tauopathy - Supplement
定义实验性 AD 和 Tau 病中 MHC I 类限制性抗原呈递至 CD8 T 细胞 - 补充
- 批准号:
10836880 - 财政年份:2023
- 资助金额:
$ 13.71万 - 项目类别:
Targeting MAL2-mediated endocytosis to enhance tumor cell antigen presentation
靶向 MAL2 介导的内吞作用以增强肿瘤细胞抗原呈递
- 批准号:
10734324 - 财政年份:2023
- 资助金额:
$ 13.71万 - 项目类别:
Antigen presentation to the adaptive immune system in the choroid contributes to ocular autoimmune disease
脉络膜中的适应性免疫系统的抗原呈递导致眼部自身免疫性疾病
- 批准号:
10740465 - 财政年份:2023
- 资助金额:
$ 13.71万 - 项目类别:
Investigation of Target Protein Degradation and Its Effect on Enhancing Cancer-Specific Antigen Presentation by Quantitative Mass Spectrometry
通过定量质谱研究靶蛋白降解及其对增强癌症特异性抗原呈递的影响
- 批准号:
23K04971 - 财政年份:2023
- 资助金额:
$ 13.71万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Promoting cancer cells' antigen presentation for serving as better targets for T cell immunotherapy
促进癌细胞的抗原呈递,作为 T 细胞免疫治疗的更好靶点
- 批准号:
2885451 - 财政年份:2023
- 资助金额:
$ 13.71万 - 项目类别:
Studentship
Targeting immunoproteasome-mediated antigen presentation in colorectal cancer immunotherapy
结直肠癌免疫治疗中靶向免疫蛋白酶体介导的抗原呈递
- 批准号:
10385926 - 财政年份:2022
- 资助金额:
$ 13.71万 - 项目类别:
Lipid Antigen Presentation as a Driver of T2D Inflammation
脂质抗原呈递作为 T2D 炎症的驱动因素
- 批准号:
10509043 - 财政年份:2022
- 资助金额:
$ 13.71万 - 项目类别:
Enhancing antigen presentation in triple negative breast cancers through CD40 agonist, Flt3 ligand, and anthracycline chemotherapy
通过 CD40 激动剂、Flt3 配体和蒽环类化疗增强三阴性乳腺癌的抗原呈递
- 批准号:
10704008 - 财政年份:2022
- 资助金额:
$ 13.71万 - 项目类别:
Sex Differences in lipid antigen presentation, impact of lipid antigen presentation on peripheral lipid metabolism
脂质抗原呈递的性别差异,脂质抗原呈递对外周脂质代谢的影响
- 批准号:
10818273 - 财政年份:2022
- 资助金额:
$ 13.71万 - 项目类别:
Enhancing antigen presentation in triple negative breast cancers through CD40 agonist, Flt3 ligand, and anthracycline chemotherapy
通过 CD40 激动剂、Flt3 配体和蒽环类化疗增强三阴性乳腺癌的抗原呈递
- 批准号:
10349397 - 财政年份:2022
- 资助金额:
$ 13.71万 - 项目类别: